Abstract: IL-17 producers in T cell subsets have been recently identified to play protective roles against bacterial infection by inducing neutrophil infiltrations, organizing granulomas and acquired immunity. During ontogeny, T cells develop, maturate and localize at different tissues depending on V repertoires. V 1+, V 4+ and V 6+ cells are reportedly able to produce IL-17. V 6+ cells, which develop in the thymus at a very early stage of ontogeny, migrate into the uterus and reproductive organs, whereas V 1+ and V 4+ cells, which develop at a later stage in the fetal thymus, migrate into the spleen, lung and liver. V 6+ cells functionally differentiate into IL-17 producers within the thymus and can consequently rapidly exert an ability to produce IL-17 in response to various stimuli. Thus, by finding IL-17-producing
INTRODUCTION
Interleukin(IL)-17 (IL-17A) was originally cloned by Rouvier et al. in 1993 and named CTLA8 which was shown to have 57% homology with the open reading frame of T lymphotropic herpesvirus samirii [1] . Since CTLA8 bound a novel cytokine receptor called IL-17 receptor (IL-17R), CTLA8 was renamed as IL-17. IL-17 is a proinflammatory cytokine mainly produced by T cells. Recently, it has been revealed that IL-17 produced by helper CD4+ T cells contributes to the induction and development of autoimmune diseases such as encephalomyelitis, inflammatory bowel disease and arthritis in mice [2] [3] [4] [5] . Due to the clinical relevance of IL-17 in autoimmune diseases, studies have focused on these fields and consequently Th17 cells as novel lineages of helper CD4+ T cells were established [6] . In addition to Th17 cells, other IL-17 producers such as CD8+
T cells, T cells and NKT cells have also been reported [7] [8] [9] . Among these populations, protective roles of T cells by orchestrating innate immunity have been reported [10] [11] [12] [13] [14] . Indeed, IL-17-producing T cells are often localized in mucosal tissues such as lung, intestine, peritoneal cavity and reproductive organs exposed to exogenous stimuli, including pathogens, where rapid responses are required as a first line of host defense. Therefore, IL-17-producing T cells can respond to various stimuli faster than Th17 cells, which are generated in the periphery under specific conditions such as autoimmune diseases. This unique feature of T cells is generated within the thymus under normal condition [15] . In this review, roles and molecular mechanisms of IL-17-producing T cells will be discussed.
BIOLOGICAL ACTIVITY OF IL-17
IL-17 is a disulfide-linked homodimeric glycoprotein consisting of 155 amino acids [16] . Homology-based cloning has recently revealed five additional IL-17 family members, *Address correspondence to these authors at the Division of Host Defense, Medical Institute of Bioregulation, Kyushu University, Japan; Tel: 81-92-642-6962; Fax: 81-92-642-6973; E-mails: k_shibata@bioreg.kyushu-u.ac.jp, yoshikai@bioreg.kyushu-u.ac.jp IL-17B to IL-17F [17] [18] [19] [20] [21] . IL-17 family members form homodimers and have a conserved C-terminal domain. Particularly, IL-17 and IL-17F share five unique, spatially conserved cysteine residues accounting for the characteristic cysteine-knot formation [22] .
IL-17 receptor A (also known as IL-17RA) was originally found as a novel receptor for IL-17. IL-17RA is a type 1 transmembrane protein consisting of a 291 amino acid extracellular domain, a 21 amino acid transmembrane domain and a 521 amino acid cytoplasmic tail. A homologybased study showed that four additional IL-17 receptor family members, IL-17RB, RC, RD and RE, have been identified so far [23] . Monoclonal antibody (mAb) treatment against IL-17RA inhibited IL-17 signaling [24] . A recent study also showed that IL-17 might bind to and signal through a IL-17RA and IL-17RC complex [25] . These results suggest that IL-17RA is indispensable for IL-17 function. IL-17RA mRNA expression was detected in the spleen, lung, liver and kidney and various cell lines such as fibroblasts, epithelial cells, endothelial cells, myeloid cells and T cells [16] . NF-B and the mitogen-activated protein kinase (MAPK) pathway were directly activated by the IL-17-mediated signal through tumor necrosis factor receptorassociated factors (TRAF6) [26] . More recently, Act1 was identified as a molecule directly binding to IL-17RA [27] . Act1 deficiency could not mount IL-17-induced inflammation in vivo and in vitro [27, 28] .
IL-17 has various but different functions depending on the cell type. The most well-documented role of IL-17 is to induce local tissue inflammation via induction of CSFs (colony-stimulating factors) and neutrophil-mobilizing cytokines. CSFs such as G-CSF and GM-CSF induce granulopoiesis by acting on myeloid cells, whereas neutrophil-mobilizing cytokines are locally produced in the inflammatory site to recruit inflammatory cells such as neutrophils and monocytes [29] . IL-17 also induces generation of osteoclasts through receptor activator of NF-B ligand (RANKL) induction [30] . IL-17 in synergy with IL-22 enhances the expression of anti-bacterial peptides [31] .
Multiple actions of IL-17 could be explained not only by the expression of IL-17RA on various cell types but also by different signaling pathways used in each cell type. Precise studies on molecular mechanisms of IL-17-mediated signaling will help us to understand overall IL-17 actions.
IDENTIFICATION OF IL-17-PRODUCING T CELLS
IL-17-producing T cells were first reported by Stark et al. using adhesion molecule-deficient mice having neutrophilia [10] . In this model, IL-17-producing T cells contributed to homeostasis by controlling neutrophil numbers in the periphery.
T cells were reported as a dominant producer of IL-17 at the site of infection at the early phase of pulmonary Mycobacterium tuberculosis infection [11] . Similarly, in pulmonary Mycobacterium bovis Bacille Calmette-Guerin (BCG) infection, IL-17-producing T cells were found in the lung at an early phase. IL-17KO mice decreased the Th1 response and impaired granuloma formation following BCG infection [12] .
IL-17-producing
T cells were also identified in the liver and spleen at an early phase after an intraperitoneal infection with Listeria monocytogenes [14, 32] . The IL-17-producing T cells which were distinct lineages from IFNproducing T cells were V 4+ and V 6+ cells. Again, infiltration of inflammatory cells and organization of granulomatous lesions were severely blocked in IL-17KO mice infected with L. monocytogenes. These results suggest that IL-17-producing T cells were directly or indirectly involved in granuloma formation following infection with intracellular bacteria. We have found that resident V 1+ T cells rapidly produced IL-17 in response to exogenous IL-23 after intraperitoneal infection with E. coli, an extracellular bacterium [13] . Antibody-mediated depletion of T cells decreased IL-17 production and neutrophil infiltration to the site of Escherichia coli infection, hampering the resolution of the infection. This result indicated that IL-17-producing T cells played an important role in protection against E. coli infection as an innate immunity (Fig. 1) . We also found that the peritoneal V 6+
T cells capable of producing IL-17 were a CD25-positive CD122-negative phenotype, while CD25-positive CD122-negative peritoneal V 6+
T cells produced IFN- [15] . Thus, IL-17-producing T cells were a distinct lineage from IFN-producing T cells.
IL-17-producing T cells have another role to induce or accelerate autoimmune diseases. In the collagen-induced arthritis (CIA) mouse model, V 4+ IL-17-producing T cells appeared during the development of CIA [33] . Treatment with Anti-V 4 mAb significantly reduced symptoms of CIA and collagen-specific IgG2a, suggesting that IL-17 produced by V 4+
T cells could be a crucial mediator for CIA development. The experimental autoimmune encephalomyelitis (EAE) mouse model has been used to study Th17 cells. It has recently been shown that IL-17-producing T cells were detected in lymph nodes at an earlier phase than Th17 cells appearing in the EAE model [34] . IL-17 production by T cells was enhanced by myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide. C KO mice immunized with MOG peptide exhibited reduced clinical scores. These results suggest that Ag-specific IL-17-producing T cells contribute to EAE induction. In the chronic granulomatous disease (CHD) mouse model, the number of V 1+ IL-17-producing T cells gradually increased in the inflammatory site and contributed to the infiltration of neutrophils [35] . 
Cytokines produced by T cells exert various immunoregulatory roles depending on their condition. For example, IFN--producing
T cells contribute to host defense by inducing a cytotoxic function, which is enhanced following the Th1 response [36] , whereas IL-10-producing T cells are often found to dampen excessive inflammations in later stages of bacterial infection [37] . In addition, skin-resident T cells produce fibroblast growth factors and keratinocyte growth factors in wound repair. By finding IL-17-producing T cell lineages, a novel function of T cells was revealed.
DEVELOPMENTAL PATHWAY AND DIVERSITY OF IL-17 PRODUCING T CELLS
Depending on the use of V chains, timing of development within the thymus and tissue distribution of T cells are tightly regulated during ontogeny. V 1+ cells paired with V 5 or V 6 chains as the first T cell lineage develop in the early fetal thymus after which V 5+ cells migrate into the skin, while V 6+ cells migrate into reproductive organs and peritoneal cavities. We have recently revealed that V 6+
T cells functionally developed into IL-17 producers within the thymus and became CD25-positive in peripheral tissues such as the peritoneal cavity and uterus [15] . V 6+ IL-17-producing T cells like Th17 cells could produce TNF-but neither IFN-nor IL-4. However, IL-17 production was not detected in V 5+ T cells in the thymus or its periphery. These results imply that the function of producing IL-17 is imprinted only on V 6+ T cells within the fetal thymus, but the mechanism whereby V 5+ and V 6+
T cells develop differently is not clear (Fig. 2) . 
IL-17 IL-23
Resident  T time differentiation remain to be clarified [33, 35] . These data indicate a relationship between tissue distribution of T cell repertoires and their IL-17-producing function. It has recently been reported that CD122-negative T cells having naïve phenotypes in the thymus and spleen produced IL-17; on the other hand, antigen-specific CD122-positive T cells produced IFN- [34] . Consistent with this, we have found that CD25-positive CD122-negative T cells in the peritoneal cavity of naive mice were able to produce IL-17, while the V 6+ IL-17-producing T cells in thymus did not express CD25 [15] . The V 6+ IL-17-producing T cells were still found in IL-2-deficient mice albeit at reduced numbers, suggesting that the IL-2 signal is not required for development in the thymus but contributes to the maintenance of V 6+ IL-17-producing T cells in the periphery. On the other hand, V 4+ IL-17-producing T cells in the spleen did not express CD25. Therefore, there might be different mechanisms in V 6+ and V 4+ cells to differentiate into IL-17 producers or to be maintained in the periphery.
It is generally accepted that the thymus is an important place to generate T cells through interaction with thymic epithelial cells (TECs). Indeed, V 1+
T cells also cannot develop in athymic mice. V 5+ and V 6+
T cells sharing V 1 chains develop in the early fetal thymus where the tissue distribution and the functions of these cells may be differently determined. Therefore, different signals from TECs in fetal thymus might explain different functions of V 5+ and V 6+
T cells, although we cannot exclude the possibility that different precursors exist. Thus, studies in thymic environments will be informative to understand the ontogeny of IL-17-producing T cells.
MECHANISMS OF IL-17 PRODUCTION BY T CELLS
We previously reported that IL-17 production was produced in a TLR4-dependent manner against E. coli infection [13] . Furthermore, IL-17 production by T cells was found to be induced in response to endogenous IL-23 released by macrophages through TLR4 stimulation. Indeed, peritoneal T cells were able to produce IL-17 in response to exogenous IL-23 in vitro. IL-23-induced IL-17 production by T cells was abolished in tyk2-deficient mice [38] . Consistently, in pulmonary Mycobacterium tuberculosis infection, IL-17 production from T cells was induced by an M. tuberculosis-infected dendritic cell-derived IL-23 in vivo and in vitro [11] . Stark et al. also showed that dendritic cell-derived IL-23 was a stimulating molecule for IL-17 production in response to LPS [10] . These results suggest that IL-17-producing T cells express IL-23 receptors which signal through tyk2 to induce IL-17 production. However, other signaling molecules involved in IL-23-mediated IL-17 production in T cells remain to be determined.
Crosslinking of TCR by mAb can induce IL-17 production, indicating that signaling from TCR is important for IL-17 production. However, ligands to the TCR remain unclear. IL-17-producing T cells in the peritoneal cavity and uterus express canonical TCRs rearranged with V 6 and V 1 chains, raising the possibility that IL-17-producing T cells might recognize endogenous proteins induced by infection. The implication of roles of IL-17-producing T cells awaits elucidation of the molecular [39] . To elucidate the functional differentiation mechanism, V 6+ IL-17-producing T cells functionally developed in fetal thymus were analyzed by using a fetal thymus organ culture system in the presence of anti-TGF-and anti-IL-6 mAbs. However, functional differentiation to IL-17-producing T cells was not blocked (unpublished observation). Consistent with this, IL-17-producing T cells in the spleen were found in the absence of IL-6 signaling [40] . IL-21 has also been reported as an important molecule for Th17 differentiation [41] . However, IL-17-producing T cells were equally found in IL-21 receptor KO mice in the periphery suggesting that an IL-21-mediated signal was not required for differentiation of IL-17-producing T cells (unpublished observation). Recently ROR t was identified as a transcription factor for Th17 cells [42] . ROR t directly binds to IL-17 promoter regions to control IL-17 production in Th17 cells [43] . However, it remains unclear whether ROR t has a similar function in IL-17-producing T cells.
FUTURE PERSPECTIVES

IL-17-producing
T cells appear in different timing of ontogeny and in different tissue from Th17 cells. These features suggest a possibility that IL-17-producing T cells not only function at different stages but also undergo different developmental pathways from Th17 cells. In contrast to Th17 cells, the molecular mechanisms of development in the thymus and functional differentiation of IL-17-producing T cells remain mostly unknown. It is expected that intensive studies on T cells will allow host defense mechanisms to be understand and applied in clinical studies.
